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Abstract 
In the present study the distribution of dopamine D2 receptors in rat spinal cord was determined by means of 
immunocytochemistry using an anti-peptide antibody, directed against the putative third intracellular loop of the 
0 2  receptor and in situ hybridization (ISH) using a [35S]UTP labelled anti-sense riboprobe. With the 
immunocytochemical technique, labelling was confined to neuronal cell bodies and their proximal dendrites. 
Strongest labelling was present in the parasympathetic area of the sacral cord and in two sexually dimorphic 
motor nuclei of the lumbosacral cord, the spinal nucleus of the bulbocavernosus and the dorsolateral nucleus. 
Moderately labelled cells were present in the intermediolateral cell column, the area around the central canal 
and lamina I of the dorsal horn. Weak labelling was present in the lateral spinal nucleus and laminae VII and Vlll 
of the ventral horn. Except for the two sexually dimorphic motornuclei of the lumbosacral cord labelled 
motoneurons were not encountered. With the ISH technique radioactive labelling was present in many neurons, 
indicating that they contained D2 receptor mRNA. The distribution of these neurons was very similar to the 
distribution obtained with immunocytochemistry, but with ISH additional labelled cells were detected in laminae Ill 
and IV of the dorsal horn, which were never labelled with immunocytochemistry. The present study shows that 
the D2 receptor is expressed in specific areas of the rat spinal cord. This distribution provides anatomical 
support for the involvement of D2 receptors in modulating nociceptive transmission and autonomic control. Our 
data further indicate that D2 receptors are not directly involved in modulating motor functions with the exception, 
possibly, of some sexual motor functions. 
Introduction 
Biochemical studies in the seventies (Magnusson, 1973; Commissiong 
and Neff, 1979) first indicated that dopamine (DA) in the spinal cord 
acted as a neurotransmitter and not solely as a precursor in the 
synthesis of other catecholamines. Anatomically, the presence of DA 
fibres in the spinal cord was first demonstrated by histofluorescence 
techniques (Bjorklund and Skagerberg, 1979; Hokfelt et al., 1979; 
Skagerberg et al., 1982). More recently, immunocytochemical studies 
using DA-specific antibodies at the light and electron microscopical 
level revealed that DA fibres and terminals existed in virtually all 
laminae throughout the spinal cord (Holstege et al., 1990; Shirouzu 
et al., 1990; Mouchet et al., 1992; Ridet et al., 1992). DA immuno- 
reactivity was most pronounced in the dorsal horn, in the area around 
the central canal, in the sympathetic intermediolateral cell column 
(IML) and in the motoneuronal cell groups. Retrograde tracing 
techniques combined with histofluorescence (Bjorklund and Skager- 
berg, 1979) or immunohistochemistry of catecholamine-synthesizing 
enzymes, like tyrosine hydroxylase (Hokfelt et al., 1979; Skagerberg 
et al., 1988) and aromatic L-amino decarboxylase (Skagerberg et al., 
1988). indicated that the spinal DA innervation originated exclusively 
from the A-ll catecholamine cell group, which is situated in the 
periventricular posterior hypothalamus. The paraventricular nucleus 
has also been implicated as a minor source for the spinal DA 
innervation (Swanson et al., 1981). Thus, the existence of an extensive 
DA innervation of the spinal cord, mainly originating from the A-1 1 
group, is now well established. 
Over the years, biochemical, pharmacological and electrophysio- 
logical studies (Barasi and Roberts, 1977; Coote et al., 1981; 
Fleetwood-Walker et al., 1988) provided evidence for specific effects 
of DA within the spinal cord which were mediated by DA receptors. 
Presently, DA receptors are subdivided in two receptor families based 
on pharmacological and biochemical criteria (for reviews see Civelli 
et al., 1991; Gingrich and Caron, 1993). These receptor families 
include DI-like receptors, which are stimulatory coupled to adenylate 
cyclase and D2-like receptors, which are either inhibitory or not 
coupled to this enzyme. Subtypes belonging to the two DA receptor 
families have been cloned and sequenced: DI-like receptors include 
the DI and D5 DA receptors, whereas D2-like receptors include the 
D2, D3 and D4 dopamine receptors. By alternate splicing of the Dz 
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receptor gene two isoforms (Dzshon and D210ng) are generated, which 
differ by a splice insert of 29 amino acids in the putative third 
intracellular loop of the D2 receptor. 'This insert is present in the long 
isoform, but is lacking in the short isoform. 
The specific distribution of DA receptors in the central nervous 
system has been studied with receptor ligand binding, ISH and more 
recently immunocytochemistry. So far, the few studies that were 
focused on the distribution of DA receptors in the spinal cord 
were mainly based on receptor ligand binding. Binding studies on 
homogenized rat spinal cord first suggested the presence of DA DI 
receptors in the spinal cord (Bhargava and Gulati, 1990) especially 
in its ventral part (Dubois et al., 1986). In contrast, D2 receptor 
binding sites were found mainly in the dorsal horn of the spinal cord 
(Demenge et al., 1980; Dubois et al., 1986; Bouthenet et a/., 1987). 
especially laminae I1 and 111 and near the central canal (Scatton e ta / . ,  
1984). More recently, an extensive binding study on the D2 receptor 
with the highly selective compound YM-0915 1-2 confirmed and 
extended these findings (Yokoyama et al., 1994) by showing additional 
binding in the IML and motoneuronal cell groups of the ventral horn. 
The presence of D2 receptor mRNA in the spinal grey matter has 
also been reported, but no anatomical details were provided (Bouthenet 
eta/ . ,  1991). However, the interpretation of the results obtained with 
the ligand binding technique is often difficult because the selectivity 
of the ligands and the anatomical resolution are limited. The immuno- 
cytochemical method provides a better anatomical resolution and may 
also be a more accurate tool to distinguish between different DA 
receptors and their subtypes than the current ligand binding techniques. 
Only after the discovery of the sequence of the D2 receptor (Bunzow 
et al., 1988) it became possible to prepare specific antibodies, using 
fusion proteins or synthetic peptides corresponding to a specific 
part of the D2 receptor. These peptide fragments have been used 
successfully for raising polyclonal antibodies against the D2 receptor 
(McVittie et al., 1991; Ariano et al., 1993; Boundy et al., 1993a, b; 
Chazot el al., 1993; Sesack et al., 1994; Smiley et al., 1994) and 
other DA receptors, including the DI and D3 receptor (Ariano and 
Sibley, 1994; Smiley etal., 1994). Some of these immunocytochemical 
studies also reported the presence of DA receptors in the spinal cord 
(Ariano et a!., 1993; Smiley et aL, 1994); however, no anatomical 
details were provided. Taken together, the available data, mostly 
based on receptor ligand binding, suggest that DA DI  receptors are 
predominantly located in the ventral horn, while D2 receptors are 
mainly localized in the dorsal horn, but may also be found in 
motoneuronal cell groups of the ventral horn. 
In the present study we have used a polyclonal antipeptide antibody 
(Plug et al., 1992) for mapping the D2 receptor in rat spinal cord. In 
addition we have applied the ISH technique to verify and extend 
the data obtained with immunocytochemistry, using an anti-sense 
[35S]UTP labelled riboprobe for detection of D2 receptor mRNA. 
Materials and methods 
Preparation and characterization of the D2 receptor antibody 
Preparation and characterization of the antibody used in the present 
study has been described previously (Plug et al., 1992). Briefly, a 
polyclonal antiserum (pAb2) was obtained from rabbits after injecting 
a synthetic peptide coupled to keyhole limpet haemocyanin. The 
peptide was derived from an amino acid sequence (amino acids 301- 
315) in the third intracellular loop of the rat D2 receptor, which is 
present in both the short and long isoform. For the purpose of the 
present study two different affinity gels were used to obtain purified 
antibodies from this antiserum: (i)  Protein A-Sepharose 6MB 
(Pharmacia) and (ii) synthetic peptide coupled directly to CNBr- 
activated Sepharose 4B. In each case 500 pl antiserum was 
incubated with 500 j.11 of the corresponding gel in a total volume of 
5 ml 10 mM Tris-HCI (pH 7.4), 250 mM NaCI. After 16 h at 4°C 
the gel suspension was transferred to a 3 ml disposable column and 
washed extensively with Tris-HCI buffer. Specific antibodies were 
eluted with 3 column vol of 0.1 M glycine-chloride (pH 2.5) and 
neutralized immediately by collecting them in 0.3 column vol 1 M 
Tns-HCI (pH 8.0). followed by addition of bovine serum albumin 
solution to a final concentration of 1 mg/ml. The collected purified 
antisera were stored frozen at -80°C until use. The antibodies obtained 
with the protein A-sepharose 6MB gel gave the most intense staining 
in all regions of the spinal cord and antibodies obtained with this 
method were mainly used for the purpose of this study. 
lmrnunocytochernistry 
Adult, male Wistar rats were deeply anaesthetized with sodium 
pentobarbital and perfused transcardially with 50 ml saline, 
followed by 500-750 ml4% (wt/vol) freshly made paraformaldehyde 
in 0.1 M phosphate buffer (pH 7.4). In some cases up to 0.054.2% 
(vol/vol) glutaraldehyde was added to the fixative and best results 
were obtained with 0.1% glutaraldehyde. The fixation liquid was 
followed by 150 ml of 1&15% (wt/vol) sucrose in phosphate buffer. 
After perfusion the brains and spinal cords were removed and stored 
overnight at 4°C in phosphate buffer containing 2 6 2 5 %  (wt/vol) 
sucrose. The next day 30 pm frozen sections were cut from all spinal 
segments and selected parts of the brain and collected in 0.1 M Tris- 
buffered saline (pH 8.6). All subsequent procedures were performed 
on free-floating sections at room temperature except where specified 
otherwise. After each step sections were thoroughly rinsed with Tris- 
buffered saline. Sections were first incubated with a solution of 5% 
(vol/vol) normal goat serum (Gibco) in Tris buffered saline containing 
0.3% (vol/vol) Triton X-100 for 90 min to reduce background staining. 
Next, sections were incubated for 24-48 h at 4°C with polyclonal D2 
receptor antipeptide antibody ( 1500) followed by biotinylated goat- 
anti-rabbit (1:200, 120 min) and the ABC procedure (ABC Elite, 
Vector). The peroxidase complex was visualized with 0.05% (wt/vol) 
3,3'-diaminobenzidine (Sigma) in 0.05 M Tris-HCI solution (pH 7.6) 
in the presence of 0.0 1 % (vol/vol) hydrogen peroxide, which yields a 
brown precipitate. In some cases 0.0 I % (wt/vol) nickel ammonium 
sulphate solution was added, which resulted in a dark blue precipitate. 
After completion of the immunocytochemical procedure sections 
were mounted on to glass slides with gelatin-chrome alum adhesive 
and allowed to dry at room temperature. Next, sections were 
dehydrated in graded ethanol baths, transferred to xylene and cover- 
slipped with Permount. Some slides were counterstained with cresyl 
violet. Sections were examined light microscopically with bright- 
field illumination. 
lmmunocytochernical controls 
Controls for the immunocytochemical methods included (i) substi- 
tution of the antipeptide antiserum with pre-immune serum; (ii) 
substitution of the primary antiserum with saline; and (iii) pre- 
adsorption of the antiserum with an excess of its peptide antigen 
( 1  mg/ml antiserum) prior to incubation. Omission of the primary 
antibody or substitution of pre-immune serum for the antipeptide 
antibody resulted in clean sections without staining. Pre-adsorption 
of the antiserum with an excess of its peptide antigen prior to 
incubation prevented neuronal staining, except for some white matter 
glia, which is, therefore, considered as background staining. Adding 
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Sections were hybridized with [35S]UTP labelled anti-sense ribo- 
probe for D2 receptor as described (Jongen-RElo et a/., 1994). After 
hybridization and stringency washing steps the sections were air 
dried, dipped into nuclear photographic emulsion (Kodak NTB-2) 
and stored in the dark (4°C). After 12-16 weeks exposure the sections 
were developed, fixed and counterstained with cresyl violet. The 
distribution of labelled neurons was analysed light microscopically 
with dark-field illumination. 
Specificity controls for the ISH included hybridization with ‘sense’ 
probe and tissue treatment with RNase prior to anti-sense probe 
hybridization. Both methods resulted in absence of labelling and 
confirmed the specificity of the hybridization signal generated by the 
radioactively labelled riboprobe. 
glutaraldehyde to the perfusion fixative resulted in reduction of 
background staining, including the white matter glia, while the 
labelling in the areas described remained, albeit less intense. 
In the brain D2 receptor immunoreactivity was found in many 
areas, among which the cerebral cortex, striatum, substantia nigra 
pars compacta, hippocampus, ventral tegmental area, superficial 
layers of superior colliculus and hypothalamus. The labelling obtained 
in brain was very similar to previous anatomical studies on the 
localization of D2 receptor using ISH (Weiner et al., 1991; Brouwer 
et al., 1992). receptor ligand binding (Dubois et al., 1986; Bouthenet 
et al., 1987; Yokoyama et al., 1994) and immunocytochemistry 
(Brock et d., 1992; Ariano et a/., 1993; Levey er al., 1993). 
We therefore concluded that the immunocytochemical labelling of 
neuronal elements obtained in the present study represented Dz 
receptor protein. 
In situ hybridization 
Rats were decapitated and their spinal cords were quickly removed 
and frozen on dry ice. Cryostat sections (10 pm) from thoracic, 
lumbar and sacral levels of the spinal cord were made and collected on 
gelatin-coated slides, air dried at room temperature and fixed with 
4% (wt/vol) paraformaldehyde solution in 0.05 M phosphate-buffered 
saline (pH 7.4). After three rinses in phosphate-buffered saline, 
sections were treated with acetic anhydride, dehydrated in graded 
ethanol baths, followed by two successive chloroform baths for 
10 min each. Next, slides were allowed to air dry and were stored 
at -70°C until further processing. 
dopamine D2 protein 
(immunocytochemistry) 
* dopamineD2mRNA 
(in situ hybridization) 
Results 
lrnmunocytochernistry 
In all positive-staining regions examined in the central nervous system 
the DAB reaction product, indicating the presence of D2 receptor 
protein, was mostly associated with neuronal cell bodies and their 
proximal dendrites, but in some cases the dendritic processes could 
be followed for some distance within a section. Application of the 
antibody on spinal cord sections resulted in a distinct pattern of 
labelled neurons. In comparison with most brain areas, labelled 
neurons in the spinal cord were few and weakly labelled. However, 
some strongly labelled neurons were also observed (see below). 
ww s2 
FIG. 1. Schematic representation showing the distribution of neurons immunoreactive for dopamine Dz receptor protein (filled dots; 1 dot = 1-3 cells) or 
radioactively labelled for Dz receptor mRNA (stars; 1 star = 3-5 cells), as revealed by immunocytochemistry and in siru hybridization. Note that no stars were 
drawn in the first segment (C4). because high cervical levels were not processed for in siru hybridization. 
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At all levels of the spinal cord labelling was found exclusively in 
cell bodies and their proximal dendrites. The immunoreactivity was 
virtually absent from other neuronal processes, like axons, small 
dendrites nor was there any indication for localization of immuno- 
reactivity in terminals. The labelled neurons were located in specific 
areas throughout the spinal cord, including the superficial dorsal horn, 
the region surrounding the central canal, the sympathetic IML and 
the sacral parasympathetic area and, to a lesser extent, in the ventral 
horn (Fig. I ) .  
In the dorsal horn densely labelled neurons were present in lamina 
I (Fig. 2A). In  every section examined, an average of one to three 
labelled cells were observed. They were found at all levels of the 
spinal cord and were distributed both medially and laterally within 
lamina I. In the lateral spinal nucleus, located in the lateral funiculus 
of the spinal cord, moderately labelled cells were occasionally present 
(Fig. 2B). At high cervical levels no labelled cells were seen in the 
lateral cervical nucleus, although it was sometimes difficult to 
delineate its boundary with the lateral spinal nucleus. In each spinal 
cord section, from high cervical to low sacral levels, on average one 
or two cells were labelled in the lateral spinal nucleus. No labelled 
cells were observed in lamina I1 and I11 of the dorsal horn. In lamina 
IV and V some scattered weakly labelled cells were present and 
occasionally a moderately labelled cell was encountered. In general, 
when going from lamina IV to laminae V and VI more labelled cells 
Fig. 2. (A-F) Light micrograph of dopamine Dl receptor protein immunoreactive cells in different areas of the rat spinal cord as indicated schematically in 
each inset. (A) Lamina I; (B) lateral spinal nucleus of the dorsal horn: (C) area around the central canal; (D) preganglionic cells of the intermediolateral cell 
column of the thoracic cord; (E)  parasympathetic area of the sacral cord; (F) sexually dimorphic rnotoneurons in the dorsolateral nucleus of the ventral 
lumbosacral cord. Scale bar = 50 pm. 
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were observed and the labelling became more intense, although they 
were still not strongly labelled. In the area around the central canal 
moderately and weakly labelled cells were present at all levels of the 
spinal cord, but they were somewhat more intense at the lumbar level 
(Fig. 2C). The labelled cells were scattered around the central canal 
and clusters of moderately labelled cells were present in the area 
immediately dorsal of the central canal. 
In the IML of the spinal cord, at thoracic and high lumbar levels, 
clusters of five to six moderately labelled cells were present (Fig. 
2D) in many, but not all sections. The labelling extended into the 
proximal dendrites radiating towards the lateral funiculus. A high 
proportion of the neurons of the IML were immunoreactive. Additional 
labelled cells were located in related areas towards the central canal 
(intercalated nuclei), but these cells were less intensely labelled. 
Strongest labelling within the spinal cord was found in cells of the 
parasympathetic area of the sacral cord (Fig. 2E) and a high proportion 
of the neurons in this area were immunoreactive. The labelled cells 
showed a dense staining of their cell bodies and proximal dendrites. 
They were arranged in clusters of four to five cells, with their 
dendrites radiating towards the lateral funiculus. In addition to these 
strongly labelled cells also several moderately labelled cells were 
present in this area. 
In the ventral horn, a few moderately and weakly labelled cells 
were present in laminae VII and VIII. In general, when going 
more ventrally, staining of labelled cells became faint. Labelled 
motoneurons were found only in the lumbosacral spinal nucleus of 
the bulbocavernosus (SNB) and dorsolateral nucleus (DLN) (Fig. 
2F), which innervate different target muscles: the DLN innervates 
the external urethral sphincter, while the SNB innervates the external 
anal sphincter and the bulbocavernosus. Motoneurons of the SNB 
and DLN were labelled equally strong and their proximal dendrites 
were also densely labelled. A light staining of the neuropil surrounding 
the SNB and DLN was observed, probably due to faint labelling of 
small dendrites, which are present in longitudinally oriented bundles. 
Labelled motoneurons were never observed at other levels of the 
spinal cord. 
In situ hybridization 
The presence of D2 receptor mRNA was detected with ISH. Radio- 
actively labelled riboprobe was hybridized to D2 receptor mRNA, 
which resulted in a distinct accumulation of silver grains over many 
cell bodies (Fig. 3A, B). 
In general, labelling of neuronal cell bodies was found in the same 
areas of the spinal grey matter as described for immunocytochemistry 
(Figs I and 3A), but in many of these areas a larger number of 
neurons were labelled with the ISH technique. Labelled cells were 
present in lamina I of the superficial dorsal horn and in the lateral 
spinal nucleus, while no labelling was seen in lamina 11. Some 
labelled cells were detected in lamina I11 and IV of the dorsal horn 
(Fig. 3A), which is in contrast with the immunocytochemical findings. 
In the base of the dorsal horn labelled cells were scattered throughout 
lamina V and VI. In the area around the central canal labelled cells 
were present in clusters, predominantly located in the area immediately 
dorsal of the central canal. In the IML of the thoracic cord clusters 
of five to six labelled cells were observed and additional labelled 
cells were present in the intercalated nuclei towards the central canal 
(Fig. 3B). In the sacral parasympathetic area labelled cells were also 
present. Furthermore, in the ventral horn some labelled cells were 
scattered throughout lamina VII and VIII. In the motoneuronal cell 
groups, however, no labelling was detected except for some labelled 
cells in the lumbosacral SNB and DLN. 
Discussion 
In the present study, for the first time the regional distribution of D2 
receptor protein and mRNA was identified in rat spinal cord using 
immunocytochemistry and ISH. The results showed a characteristic 
Fig. 3. Darkfield microautoradiographs of selected parts of the rat spinal cord 
showing accumulation of silver grains over neurons containing detecting 
dopamine D2 receptor mRNA hybridized to '5S-labelled riboprobe. (A) 
Lumbar cord; (B)  lateral horn of thoracic cord. Scale bar = 200 pm and 50 
pm respectively. 
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distribution of D2 receptors throughout the spinal cord, providing 
anatomical support for the involvement of D2 receptors in the effects 
of DA in the spinal cord. 
Technical considerations 
The observation that D2 receptor immunoreactivity was located 
mainly within the somata and proximal dendrites of labelled neurons 
is in agreement with other studies using different D2 receptor 
antibodies (Brock et a/ . ,  1992; Ariano et al., 1993). A subsequent 
study (Fisher e ta / . ,  1994) at the electron microscopical level showed 
that in neostriatal neurons the D2 receptor immunoreactivity was 
uniformly present throughout the somatic cytoplasm and became less 
strong towards the periphery. The immunoreactivity was not associated 
with any cellular organelle. Some axon terminals contained traces 
of immunoreactivity, but labelled postsynaptic densities were not 
described. These findings may suggest that the antibody only recog- 
nized D2 receptor protein before its incorporation as a functional 
receptor into the neuronal membrane or during its degradation. If this 
also holds true for the antibody used in the present study, it would 
explain that only cell somata and proximal dendrites were stained. 
On the other hand, if the antibody would recognize both functional 
and non-functional receptors, our results would indicate that the 
highest proportion of D2 receptor protein is located within the cell 
body and proximal dendrites while there are only minute amounts of 
functional receptors in more distal dendrites. 
The long exposure times (up to 3 months) that were needed to 
visualize the radioactively labelled riboprobe indicated that the 
hybridization signal was relatively low. Similarly, with immunocyto- 
chemistry it was noted that, compared with other parts of the central 
nervous system, the spinal cord contained relatively few cells that 
were immunoreactive for the D2 receptor and that most of them were 
not strongly labelled. Thus, it seems likely that in comparison with 
other brain areas the level of D2 receptors in rat spinal cord is low 
both at the protein and mRNA level. Owing to these low expression 
levels the total number of cells expressing D2 receptors may have 
been underestimated. 
Distribution of D2 receptors in spinal cord 
The results of the present study showed that the D2 receptor is 
expressed in several areas of the rat spinal cord. In all spinal segments 
investigated with immunocytochemistry or ISH, the distribution 
obtained with each technique was very similar, i.e. all areas with 
neurons immunoreactive for D2 receptor protein also showed neurons 
expressing D2 receptor mRNA, although more labelled cells were 
detected with ISH. 
With immunocytochemistry, strongest labelling was present in 
neuronal cell bodies located in the sacral parasympathetic area and 
in the lumbosacral SNB and DLN. Moderately labelled cells were 
present in the IML, in the area around the central canal and in lamina 
I of the superficial dorsal horn, while weak labelling was present in 
neuronal cell bodies located in the lateral spinal nucleus and lamina 
VII and VIII of the ventral horn. The results obtained with ISH 
confirmed this distribution and extended the immunocytochemical 
findings by showing additional labelled cells in lamina 111 and IV of 
the dorsal horn, an area which was never labelled with immunocyto- 
chemistry. This difference may be explained by the fact that in this 
region the concentration of D2 receptor protein may be very low and, 
therefore, undetectable with immunocytochemistry. As a consequence 
our findings indicate that for detection of D2 receptor expression in 
the spinal cord the ISH technique may be a more sensitive technique 
than the immunocytochemistry technique. Finally, it should be 
noted that the identification of the spinal laminae and nuclei was 
based on cytological and topographical criteria. As a consequence, 
in the sacral parasympathetic area there is no direct evidence that 
neurons expressing the D2 receptor actually represent para- 
sympathetic preganglionic neurons, as strongly suggested by their 
location. This can only be ascertained by using double-labelling 
studies which combine D2 receptor localization with the appropriate 
technique for identifying specific neurons. 
Previous studies on the regional distribution of D, receptors in 
spinal cord all used the receptor ligand binding technique. Ligand 
binding was reported in the dorsal horn (Scatton et al., 1984; Dubois 
et al., 1986; Bouthenet et al., 1987; Yokoyama et al., 1994), the 
area around the central canal (Scatton et al., 1984; Yokoyama er al., 
1994), the IML and in motoneurons (Yokoyama et a/ . ,  1994). Our 
findings are in agreement with these binding studies, but differed 
from the reported binding in the substantia gelatinosa and in the 
motoneuronal cell groups, areas which showed neither immuno- 
reactivity nor hybridization signal. However, it must be kept in mind 
that the binding pattern may differ from the cellular distribution 
obtained with ISH or immunocytochemistry, because the functional 
D2 receptors, i.e. the binding sites, may be located on dendrites of 
neurons which have their cell somata in another lamina of the spinal 
cord. With respect to the binding found in the substantia gelatinosa 
our findings indicate that the parent cell bodies of these D2 receptor 
binding sites are located outside the substantia gelatinosa of the dorsal 
horn (lamina 11). On the other hand, the ligands may also bind to other 
receptors of the D2 receptor family, due to a lack of pharmacological 
selectivity which is inherent to the receptor ligand binding technique. 
This may be true especially for the reported ligand binding in spinal 
motoneurons (Yokoyama e ta / . ,  1994), because neither binding studies 
nor in situ hybridization studies have described the presence of D2 
receptors in motoneurons. Moreover, we never observed D2 receptor 
labelling in motoneurons outside the lumbosacral SNB and DLN. 
Therefore, we consider the presence D2 receptors in spinal motoneu- 
rons, except the SNB and DLN, most unlikely. 
Functional aspects 
The distribution of D2 receptors in rat spinal cord, as demonstrated 
with immunocytochemistry and ISH, suggests that D2 receptors may 
play a part in the transmission of sensory information and autonomic 
processing. Our results also indicate that D2 receptors are not directly 
involved in modulation of motoneurons, with the exception of 
motoneurons in the SNB and DLN of the lumbosacral cord. 
Several studies indicate that spinal DA and, more specifically, D2 
receptors play an inhibitory part in the transmission of nociceptive 
stimuli. It has been reported that intrathecally administered D2 receptor 
agonists produced a reversible reduction of thalamic nociceptive 
responses to noxious stimuli (Clatworthy and Barasi, 1987). Further- 
more, focal electrical stimulation in the region of the A- 1 I cell group 
selectively suppressed nociceptive responses of spinal multireceptive 
neurons (Fleetwood-Walker et al., 1988). This inhibition was rapidly 
reversed by ionophoresis of the D2 receptor antagonist sulpiride in the 
superficial and deeper dorsal horn. Similarly, D? receptor antagonists 
antagonized the antinociceptive effects induced by intrathecally 
applied DA (Liu et a/., 1992). In contrast, neither the DI receptor 
agonist SKF38393 nor D1 receptor antagonist SCH23390 showed 
any effect on the DA-induced antinociception (Barasi et al., 1987; 
Liu et a/ . ,  1992). These findings suggest that the DA-induced 
antinociceptive effects are mediated via spinal D2 receptors located 
in the superficial and deeper dorsal horn. This is in good agreement 
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with the regional distribution of D2 receptors in the dorsal horn as 
described in the present study. 
The presence of D2 receptors in the IML of the thoracic and high 
lumbar cord is in agreement with its dense DA innervation (Yoshida 
and Tanaka, 1988; Holstege et al., 1990; Shirouzu et al., 1990; 
Mouchet et al., 1992; Ridet et al., 1992). Apomorphine and other, 
more selective, D2 receptor agonists administered intrathecally down- 
regulated autonomic functions, resulting in hypotension and brady- 
cardia (Petitjean et al., 1984; Clatworthy and Barasi, 1987; Pellissier 
and Demenge, 1991; Lahlou and Demenge, 1993). Our findings 
suggest that the inhibition by DA of preganglionic cells of the IML 
is mediated by D2 receptors. 
D2 receptors were found to  be most prominent in neurons of the 
sacral parasympathetic area and the lumbosacral SNB and DLN, 
which innervate anatomically distinct perineal muscles that are 
involved in functionally distinct copulatory reflexes. Previous studies 
have shown that DA agonists inhibit specific sexual motor functions 
like penile reflexes (Stefanick et al., 1982; Pehek et al., 1989). Our 
results provide some anatomical support for the involvement of D2 
receptors located in the lumbosacral cord in the regulation of sexual 
motor behaviour at the spinal level. 
There is also some evidence favouring the idea that DA is involved 
in the control of spinal motor functions. Although DA is present in 
the ventral cord, including motoneuronal cell groups, our results 
indicate that D2 receptors are not directly involved in modulating 
motoneuron activity. The reported effects of DA on somatic motor 
functions at the spinal level are contradictory. DA receptor mediated 
depression of the spinal monosynaptic transmission has been reported 
(Carp and Anderson, 1982; Ono and Fukuda, 1984) and denied 
(Kamijo et al., 1993). Recently, it has been reported that DA 
enhances glutamate-activated currents in cultured chick embryo spinal 
motoneurons. The enhancement was diminished by the D ,  receptor 
antagonist SCH23390 and mimicked by the (partial) D I  receptor 
agonist SKF38393 (Smith et al., 1995). These findings suggest that 
in the motoneuronal cell groups the presence of DA and, more 
particularly, the absence of D2 receptor labelling in motoneurons may 
indicate that other DA receptors, like D I  receptors, are more important 
in this part of the spinal cord. 
It may be concluded that the D2 receptors are expressed in specific 
areas of the rat spinal cord. Although the level of D2 receptor in 
spinal cord may be much lower than in the brain, several physiological 
studies indicate that activation of spinal D2 receptors has important 
functional consequences. Their distribution provides anatomical sup- 
port for the involvement of spinal D2 receptors in the modulation of 
nociceptive transmission and autonomic control. Our data further 
indicate that spinal D2 receptors are not directly involved in modulating 
motor functions at the motoneuronal level with the possible exception 
of some sexual motor functions. However, it should be mentioned 
that motor functions may be modulated indirectly via D2 receptors 
located in the dorsal horn or at supraspinal levels. In order to elucidate 
further the role of DA in modulating spinal cord functioning further 
investigation of various types of DA receptors in the spinal cord 
needs to be undertaken. 
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